| Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin S Dalva-Aydemir, R Bajpai, M Martinez, KUA Adekola, I Kandela, C Wei, ... Clinical Cancer Research 21 (5), 1161-1171, 2015 | 145 | 2015 |
| Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax R Bajpai, SM Matulis, C Wei, AK Nooka, HE Von Hollen, S Lonial, ... Oncogene 35 (30), 3955-3964, 2016 | 98 | 2016 |
| Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma R Bajpai, A Sharma, A Achreja, CL Edgar, C Wei, AA Siddiqa, VA Gupta, ... Nature communications 11 (1), 1228, 2020 | 73 | 2020 |
| In silico modeling-based identification of glucose transporter 4 (GLUT4)-selective inhibitors for cancer therapy RK Mishra, C Wei, RC Hresko, R Bajpai, M Heitmeier, SM Matulis, ... Journal of Biological Chemistry 290 (23), 14441-14453, 2015 | 72 | 2015 |
| Specificity protein 1: Its role in colorectal cancer progression and metastasis R Bajpai, GP Nagaraju Critical reviews in oncology/hematology 113, 1-7, 2017 | 57 | 2017 |
| Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer N Bar, F Costa, R Das, A Duffy, M Samur, S McCachren, SN Gettinger, ... JCI insight 5 (12), 2020 | 56 | 2020 |
| Redox biology of Mycobacterium tuberculosis H37Rv: protein-protein interaction between GlgB and WhiB1 involves exchange of thiol-disulfide S Garg, MS Alam, R Bajpai, KVR Kishan, P Agrawal BMC biochemistry 10, 1-12, 2009 | 51 | 2009 |
| Development of GLUT4-selective antagonists for multiple myeloma therapy C Wei, R Bajpai, H Sharma, M Heitmeier, AD Jain, SM Matulis, AK Nooka, ... European journal of medicinal chemistry 139, 573-586, 2017 | 49 | 2017 |
| A1 and A2 sub-types of blood group ‘A’: A Reflection of their prevalence in North Karnataka region SS Giriyan, A Agrawal, R Bajpai, NK Nirala Journal of Clinical and Diagnostic Research: JCDR 11 (5), EC40, 2017 | 32 | 2017 |
| Co-inhibition of BET and proteasome enhances ER stress and Bim-dependent apoptosis with augmented cancer therapeutic efficacy G Qian, W Yao, S Zhang, R Bajpai, WD Hall, M Shanmugam, S Lonial, ... Cancer Letters 435, 44-54, 2018 | 28 | 2018 |
| Targeting KDM4 for treating PAX3-FOXO1–driven alveolar rhabdomyosarcoma S Singh, A Abu-Zaid, H Jin, J Fang, Q Wu, T Wang, H Feng, W Quarni, ... Science translational medicine 14 (653), eabq2096, 2022 | 17 | 2022 |
| Study of utilization of blood and blood components in a tertiary care hospital SS Giriyan, HD Chethana, N Sindhushree, A Agarwal, NK Nirala, ... J Blood Lymph 7 (2), 169, 2017 | 15 | 2017 |
| Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia DC Ferguson, JR McCorkle, KR Barnett, EJ Bonten, BP Bergeron, ... Blood Advances 6 (11), 3386-3397, 2022 | 8 | 2022 |
| Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication Y Liu, J Klein, R Bajpai, L Dong, Q Tran, P Kolekar, JL Smith, RE Ries, ... Nature communications 14 (1), 1739, 2023 | 7 | 2023 |
| Targeting cancer metabolism through synthetic lethality-based combinatorial treatment strategies R Bajpai, M Shanmugam Current Opinion in Oncology 30 (5), 338-344, 2018 | 7 | 2018 |
| Genome sequence of a novel actinophage PIS136 isolated from a strain of Saccharomonospora sp R Bajpai, V Soni, L Khandrika, PK Jangir, R Sharma, P Agrawal Journal of virology 86 (17), 9552-9552, 2012 | 5 | 2012 |
| The MLL3/4 complexes and MiDAC co-regulate H4K20ac to control a specific gene expression program X Wang, W Rosikiewicz, Y Sedkov, B Mondal, T Martinez, ... Life Science Alliance 5 (11), 2022 | 2 | 2022 |
| Methods of treating cancer with a combination of glucose modulators and bcl-2 inhibitors M Shanmugam, R Bajpai, L Boise US Patent App. 14/919,224, 2016 | 2 | 2016 |
| The F-box-only protein 44 regulates pregnane X receptor protein level by ubiquitination and degradation RRF Gee, AD Huber, J Wu, R Bajpai, AJ Loughran, SM Pruett-Miller, ... Acta Pharmaceutica Sinica B 13 (11), 4523-4534, 2023 | 1 | 2023 |
| Patient derived model of UBA5-associated encephalopathy identifies defects in neurodevelopment and highlights potential therapies H Chen, YD Wang, AW Blan, EP Almanza-Fuerte, ES Bonkowski, ... bioRxiv, 2024.01. 25.577254, 2024 | | 2024 |
